115 results
DEFA14A
KPTI
Karyopharm Therapeutics Inc
19 Apr 24
Additional proxy soliciting materials
7:44am
Materials
Soliciting Material Under §240.14a-12
Karyopharm Therapeutics Inc.
(Name of Registrant as Specified in its Charter)
(Name of Person(s … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
Important Notice Regarding
SC TO-C
KPTI
Karyopharm Therapeutics Inc
8 Apr 24
Information about tender offer
5:08pm
”) if and when the Option Exchange Program commences. Option holders should read the Tender Offer Statement on Schedule TO and other related materials when … those materials become available, because they will contain important information about the Option Exchange Program.
The Company’s stockholders
SC TO-C
EX-99.2
KPTI
Karyopharm Therapeutics Inc
8 Apr 24
Information about tender offer
5:08pm
to participate in the exchange program with written materials explaining the precise terms and timing of the program. You should read these materials carefully
DEFA14A
aw5622i50 u53
11 Apr 23
Additional proxy soliciting materials
8:11am
D
s11xx526
8 Dec 22
$165.00 mm in equity / options / securities to be acquired, sold $165.00 mm, 33 investors
4:07pm
8-K
EX-3.1
zkbd5gswicj1og
2 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:05pm